• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量分析鉴定 Notch 信号通路的激活剂。

High-Throughput Analysis to Identify Activators of Notch Signaling.

机构信息

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.

Department of Otolaryngology - Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Methods Mol Biol. 2022;2472:49-56. doi: 10.1007/978-1-0716-2201-8_5.

DOI:10.1007/978-1-0716-2201-8_5
PMID:35674891
Abstract

The Notch pathway regulates many cellular functions in a context-dependent manner. Depending on the cell type, either the activation or inhibition of Notch signaling can influence many processes such as cellular proliferation, specification, differentiation, and survival. The activation of Notch signaling has been shown to have therapeutic advantages in some cancers, thus having a method to identify Notch-activating compounds is needed. In this chapter we outline a method for high-throughput analysis of potential Notch pathway activators in a pancreatic neuroendocrine tumor cell line as an example. We also include the steps for subsequent validation of results and preclinical testing.

摘要

Notch 通路以依赖于上下文的方式调节多种细胞功能。根据细胞类型的不同, Notch 信号的激活或抑制均可影响多种过程,如细胞增殖、分化、特化和存活。 Notch 信号的激活已被证明在某些癌症中具有治疗优势,因此需要有一种方法来鉴定 Notch 激活化合物。在本章中,我们概述了一种在胰腺神经内分泌肿瘤细胞系中高通量分析潜在 Notch 通路激活剂的方法,作为示例。我们还包括了后续验证结果和临床前测试的步骤。

相似文献

1
High-Throughput Analysis to Identify Activators of Notch Signaling.高通量分析鉴定 Notch 信号通路的激活剂。
Methods Mol Biol. 2022;2472:49-56. doi: 10.1007/978-1-0716-2201-8_5.
2
Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.通过一种新型高通量筛选方法鉴定和验证 Notch 通路激活化合物。
Cancer. 2011 Apr 1;117(7):1386-98. doi: 10.1002/cncr.25652. Epub 2010 Nov 8.
3
Notch Signaling in Thyroid Cancer. Notch 信号通路在甲状腺癌中的作用。
Adv Exp Med Biol. 2021;1287:155-168. doi: 10.1007/978-3-030-55031-8_10.
4
miR‑125b‑mediated regulation of cell proliferation through the Jagged‑1/Notch signaling pathway by inhibiting BRD4 expression in psoriasis.miR-125b 通过抑制 BRD4 表达调控细胞增殖,Jagged-1/Notch 信号通路在银屑病中起作用。
Mol Med Rep. 2019 Jun;19(6):5227-5236. doi: 10.3892/mmr.2019.10187. Epub 2019 Apr 24.
5
Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer.配体依赖性Notch信号通路参与胰腺癌的肿瘤起始和肿瘤维持过程。
Clin Cancer Res. 2009 Apr 1;15(7):2291-301. doi: 10.1158/1078-0432.CCR-08-2004. Epub 2009 Mar 3.
6
Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma.JAG1 的上调增强了肾上腺皮质癌中的细胞增殖。
Clin Cancer Res. 2012 May 1;18(9):2452-64. doi: 10.1158/1078-0432.CCR-11-2371. Epub 2012 Mar 16.
7
Notch signaling in solid tumors.实体瘤中的 Notch 信号通路。
Curr Top Dev Biol. 2010;92:411-55. doi: 10.1016/S0070-2153(10)92013-9.
8
Crosstalk between the Notch signaling pathway and long non-coding RNAs.Notch 信号通路与长链非编码 RNA 的相互作用。
Cancer Lett. 2018 Apr 28;420:91-96. doi: 10.1016/j.canlet.2018.01.070. Epub 2018 Feb 2.
9
Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.胶质母细胞瘤肿瘤干细胞中信号转导子和转录激活子 3(STAT3)和核因子 κB 信号的组成性激活调节 Notch 通路。
J Biol Chem. 2013 Sep 6;288(36):26167-26176. doi: 10.1074/jbc.M113.477950. Epub 2013 Jul 31.
10
Notch signaling and malignant melanoma.Notch 信号通路与恶性黑色素瘤。
Adv Exp Med Biol. 2012;727:258-64. doi: 10.1007/978-1-4614-0899-4_19.

本文引用的文献

1
Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth .组蛋白去乙酰化酶抑制剂泰国辛-A激活Notch信号通路并抑制神经内分泌癌细胞生长。
Oncotarget. 2017 Aug 7;8(41):70828-70840. doi: 10.18632/oncotarget.19993. eCollection 2017 Sep 19.
2
A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.一项用丙戊酸治疗低级别神经内分泌癌的初步 II 期研究。
Oncologist. 2011;16(6):835-43. doi: 10.1634/theoncologist.2011-0031. Epub 2011 May 31.
3
Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.
通过一种新型高通量筛选方法鉴定和验证 Notch 通路激活化合物。
Cancer. 2011 Apr 1;117(7):1386-98. doi: 10.1002/cncr.25652. Epub 2010 Nov 8.
4
Hesperetin, a potential therapy for carcinoid cancer.橙皮素,一种用于类癌肿瘤治疗的潜在药物。
Am J Surg. 2011 Mar;201(3):329-32; discussion 333. doi: 10.1016/j.amjsurg.2010.08.018.
5
Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.白藜芦醇诱导神经内分泌标志物在甲状腺髓样癌中 Notch2 介导的细胞凋亡和抑制。
Ann Surg Oncol. 2011 May;18(5):1506-11. doi: 10.1245/s10434-010-1488-z. Epub 2010 Dec 24.
6
Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.表皮Notch1缺失通过影响基质微环境促进皮肤肿瘤发生。
Cancer Cell. 2009 Jul 7;16(1):55-66. doi: 10.1016/j.ccr.2009.05.016.
7
Valproic acid induces Notch1 signaling in small cell lung cancer cells.丙戊酸诱导小细胞肺癌细胞中的Notch1信号通路。
J Surg Res. 2008 Jul;148(1):31-7. doi: 10.1016/j.jss.2008.03.008. Epub 2008 Apr 10.
8
Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.辛二酰双羟肟酸在甲状腺髓样癌动物模型中激活Notch1信号通路并抑制肿瘤进展。
Ann Surg Oncol. 2008 Sep;15(9):2600-5. doi: 10.1245/s10434-008-0006-z. Epub 2008 Jun 18.
9
p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity.p53 同源物 p51/p63 通过抑制 Notch1 活性维持角质形成细胞干细胞的不成熟状态。
Oncogene. 2007 Jul 5;26(31):4478-88. doi: 10.1038/sj.onc.1210235. Epub 2007 Jan 22.
10
Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.NOTCH1细胞内结构域的过表达抑制细胞增殖并改变甲状腺髓样癌细胞的神经内分泌表型。
J Biol Chem. 2006 Dec 29;281(52):39819-30. doi: 10.1074/jbc.M603578200. Epub 2006 Nov 7.